Aside from FL and DLBCL, alterations in specific anti-apoptotic BCL-2 family members have not been well-characterized or associated with other B cell lymphomas, which is likely due to the lack of a comprehensive analysis prior to the one we recently published (9). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.